Research study Program year 2023 Source: CMS Open Payments

Phase II PoCP

Research payments

$679,157

742 payments

Through program year 2023, $679,157 in research payments was reported against Phase II PoCP, across 742 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim France S.A.S.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2023	Research	$500	1
2022	Research	$90,394	13
2021	Research	$523,064	537
2020	Research	$65,198	191

Breakdown

Who paid Research payments · program years 2020–2023

Boehringer Ingelheim Pharmaceuticals, Inc. $577,806 39 payments
Boehringer Ingelheim France S.A.S. $101,351 703 payments

Who received the money Research payments · program years 2020–2023

St Francis Holdings LLC Organisation paid for research $98,119 3 payments
U Of Utah Neuropsychiatric Institute Teaching hospital · UT $82,175 3 payments
University Of Kansas Medical Center Organisation paid for research $81,387 58 payments
Mayo Clinic Organisation paid for research $74,362 62 payments
Southeastern Research Center Organisation paid for research $73,987 69 payments
Creighton University Organisation paid for research $33,343 2 payments
Temple University Of The Commonwealth Organisation paid for research $27,014 4 payments
University of Florida Office of Clinical Organisation paid for research $25,968 1 payment
The Ohio State University Organisation paid for research $25,836 1 payment
The Lung Research Center Organisation paid for research $20,166 58 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.